These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20386562)

  • 1. Targeted therapy for systemic sclerosis: how close are we?
    Ramos-Casals M; Fonollosa-Pla V; Brito-Zerón P; Sisó-Almirall A
    Nat Rev Rheumatol; 2010 May; 6(5):269-78. PubMed ID: 20386562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of systemic sclerosis.
    Allanore Y; Kahan A
    Joint Bone Spine; 2006 Jul; 73(4):363-8. PubMed ID: 16495105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative therapies for systemic sclerosis.
    Ong VH; Denton CP
    Curr Opin Rheumatol; 2010 May; 22(3):264-72. PubMed ID: 20190640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathways as novel therapeutic targets in systemic sclerosis.
    Trojanowska M; Varga J
    Curr Opin Rheumatol; 2007 Nov; 19(6):568-73. PubMed ID: 17917537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiologic aspects of systemic sclerosis].
    Gran JT; Molberg Ø; Midtvedt Ø
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2622-3. PubMed ID: 16215604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis.
    Leask A
    Pharmacol Res; 2011 Jun; 63(6):502-3. PubMed ID: 21315153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
    Hasegawa M; Takehara K
    Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs and therapeutics for systemic sclerosis.
    Lee JJ; Pope JE
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):421-430. PubMed ID: 27813423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.
    Distler O; Cozzio A
    Semin Immunopathol; 2016 Jan; 38(1):87-95. PubMed ID: 26577237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic sclerosis: Recent insights.
    Elhai M; Avouac J; Kahan A; Allanore Y
    Joint Bone Spine; 2015 May; 82(3):148-53. PubMed ID: 25557659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic sclerosis : What is currently available for treatment?].
    Becker MO
    Internist (Berl); 2016 Dec; 57(12):1155-1163. PubMed ID: 27796473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of systemic sclerosis: insights into systemic sclerosis pathogenesis and potential therapeutic approaches.
    Christner PJ; Jimenez SA
    Curr Opin Rheumatol; 2004 Nov; 16(6):746-52. PubMed ID: 15577614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive therapies in systemic sclerosis.
    Riemekasten G; Sunderkötter C
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii49-51. PubMed ID: 16987836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies.
    Distler JH; Distler O
    Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i48-51. PubMed ID: 19995744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets.
    Sacchetti C; Bottini N
    Curr Rheumatol Rep; 2017 May; 19(5):28. PubMed ID: 28397126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta (TGF-beta) and its role in the pathogenesis of systemic sclerosis: a novel target for therapy?
    Derk CT
    Recent Pat Inflamm Allergy Drug Discov; 2007 Jun; 1(2):142-5. PubMed ID: 19075976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of systemic sclerosis: the art and science.
    Stone JH; Wigley FM
    Semin Cutan Med Surg; 1998 Mar; 17(1):55-64. PubMed ID: 9512108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the treatment of systemic sclerosis.
    Bournia VK; Vlachoyiannopoulos PG; Selmi C; Moutsopoulos HM; Gershwin ME
    Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):176-200. PubMed ID: 19132559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for the treatment of scleroderma: a review of recent phase 2 and 3 trials.
    Roofeh D; Lescoat A; Khanna D
    Expert Opin Emerg Drugs; 2020 Dec; 25(4):455-466. PubMed ID: 33054463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
    Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.